Figure 2.

Comparative safety of mRNA COVID‐19 vaccines versus influenza vaccines with respect to serious adverse events after immunization (AEFIs). Adj‐ROR, adjusted reported odd ratios; 95% CI, 95% confidential interval; mRNA, messenger RNA

Comparative safety of mRNA COVID‐19 vaccines versus influenza vaccines with respect to serious adverse events after immunization (AEFIs). Adj‐ROR, adjusted reported odd ratios; 95% CI, 95% confidential interval; mRNA, messenger RNA